Ramsay M A, Savege T M, Simpson B R, Goodwin R
Br Med J. 1974 Jun 22;2(5920):656-9. doi: 10.1136/bmj.2.5920.656.
Alphaxalone-alphadolone (Althesin), diluted and administered as a controlled infusion, was used as a sedative for 30 patients in an intensive therapy unit. This technique allowed rapid and accurate control of the level of sedation. It had three particularly useful applications: it provided "light sleep," allowed rapid variation in the level of sedation, and enabled repeated assessment of the central nervous system.Sedation was satisfactory for 86% of the total time, and no serious complications were attributed to the use of the drug. Furthermore, though alphaxalone-alphadolone was given for periods up to 20 days there was no evidence of tachyphylaxis or delay in recovery time.
将阿法沙龙-阿法多龙(阿尔泰辛)稀释后作为控制输注药物,用于重症监护病房的30例患者作为镇静剂。这种技术能快速、准确地控制镇静水平。它有三个特别有用的用途:提供“浅睡眠”,允许镇静水平快速变化,并能对中枢神经系统进行反复评估。在总时长的86%时间里镇静效果令人满意,且未发现因使用该药物导致的严重并发症。此外,尽管阿法沙龙-阿法多龙的给药时间长达20天,但没有证据表明出现快速耐受性或恢复时间延迟。